KBRA Releases RMBS Credit Indices (KCI) for April 2022
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its RMBS Credit Indices (KCI) for April 2022. The indices track…
News
KBRA Releases Research – Home Improvement Loan Sector on the Rise
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research on the home improvement loan (HIL) asset-backed security (ABS) sector….
KBRA Releases Solar Loan Index for April 2022
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its solar loan index publication, providing monthly credit trends of securitized…
Alight Report Finds Accessible Benefits Programs Matter When It Comes to Creating an Inclusive Workplace
Employees want wellbeing programs that meet their unique needs, and those of a diverse workforce…
TotalEnergies and Ørsted Partner to Participate in Dutch Offshore Wind Tenders
PARIS & DEN HAAG, Netherlands–(BUSINESS WIRE)–Regulatory News: TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE) and Ørsted have joined…
9 Questions You Should Ask About Your Cloud Security
Josh Stella Explains Why Business Leaders Often Lack Critical Insights Into the Security of their…
Delta Payment Solutions Appoints Stacey Wiles as New CEO
BOSTON–(BUSINESS WIRE)–#deltacooperative—Delta Payment Solutions, the management arm of Delta Payment Cooperative, is happy to announce…
Palisade Bio Reports First Quarter 2022 Financial Results and Provides Corporate Update
Phase 3 study of LB1148 in lead indication for postoperative return of bowel function on…
Ceapro Inc. Present PGX Enabling Technology Case Study at the 13th International Symposium on Supercritical Fluids
PGX Technology continues to demonstrate ability to generate novel bioactive delivery systems for nutraceuticals, drug…
ABVC BioPharma Engages the FreeMind Group to Support Grant Funding
FREMONT, CA, May 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ:…
Checkpoint Therapeutics Receives Pediatric Investigational Plan Waivers for Cosibelimab from the European Medicines Agency and U.K. Medicines & Healthcare Products Regulatory Agency
Waivers remove requirement to conduct pediatric clinical studies to support cosibelimab marketing authorization applications in…
POINT Biopharma Reports First Quarter 2022 Financial Results and Provides Business Update
POINT’s manufacturing facility initiated supply for the Phase 3 SPLASH trial. Randomization of patients for…
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
PHILADELPHIA, PA, May 13, 2022 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or…
Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2022 and Provides Corporate Update
ONS-5010 / LYTENAVA™ (bevacizumab-vikg) Biologics License Application (BLA) submitted to U.S. Food and Drug Administration…
Pyxis Oncology Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update
CAMBRIDGE, Mass., May 13, 2022 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a multi-asset…
CytoDyn Announces the Addition of Leading Experts in Oncology, Infectious Diseases, and Neuroinflammation to its Scientific Board of Advisors; Dr. Jay Lalezari to Serve as Outside Scientific Advisor
VANCOUVER, Washington, May 13, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the…
Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference
SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc….
Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results
Conference call scheduled for 8:30 a.m. ET today MIAMI, May 13, 2022 (GLOBE NEWSWIRE) —…
Tempest Reports First Quarter 2022 Financial Results and Provides Corporate Highlights
Announced oral presentation of TPST-1120 Phase 1 monotherapy and combination therapy data at ASCO Presented…
SeqLL Provides First Quarter 2022 Financial Results and a Corporate Update
BILLERICA, Mass., May 13, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:…